糖尿病相关干眼的研究进展

doi:10.3760/cma.j.issn.1674-845X.2014.09.014

摘要
图/表
参考文献(54)
相关文章 (15)

全文: PDF 7252KB HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要

糖尿病在全世界发病率普遍增高，糖尿病可引起干眼、角膜病、糖尿病视网膜病变、青光眼、白内障、屈光异常改变等一系列眼部并发症，严重影响视力甚至失明。近些年糖尿病对眼表造成损害正逐渐引起临床医师关注，糖尿病相关干眼主要表现为角膜上皮反复剥脱、上皮再生延迟、角膜敏感性下降等，这主要与糖尿病条件下泪液异常、泪液渗透压升高、泪膜稳定性差、角膜神经退行性改变等异常有关。现将糖尿病相关干眼的主要临床特点结合泪液变化、角膜神经敏感性变化、血糖水平、病程、降糖药物等相关影响因素以及特殊诊断方法和治疗策略等方面的进展进行总结，为临床诊断和治疗提供理论依据。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	朱奕睿
	陈蔚

关键词 ：糖尿病, 干眼, 泪液, 角膜

Abstract：

The incidence of diabetes mellitus has generally increased all over the world. Diabetes mellitus causes several complications， including dry eye， diabetic keratopathy， diabetic retinopathy， glaucoma， cataract， and ametropia， which seriously decrease visual acuity and even cause blindness. The correlation of diabetes mellitus and ocular surface complications is significantly elevated. Dry eye in diabetes mellitus mainly exhibits several clinical features that include recurring corneal epithelial exfoliation， the delay of corneal epithelial regeneration， and a decrease in corneal sensitivity. These anomolies are mainly caused by changes in tears， increasing tear film osmolarity， unstable tear film， and corneal nerve damage in hyperglycemic conditions. This paper briefly reviews research on the factors that influence dry eye in diabetes mellitus along with clinical features， and discusses new detection methods and treatment strategies.

Key words： Diabetes mellitus Dry eye Tear Cornea

收稿日期: 2014-05-07

通讯作者: 陈蔚，Email：chenweimd@hotmail.com

引用本文:

朱奕睿,陈蔚. 糖尿病相关干眼的研究进展[J]. 中华眼视光学与视觉科学杂志, 2014, 16(9): 568-572. Zhu Yirui,Chen Wei. Research progress on dry eye in diabetes mellitus. Chinese Journal of Optometry Ophthalmology and Visual science, 2014, 16(9): 568-572. DOI: 10.3760/cma.j.issn.1674-845X.2014.09.014

链接本文:

https://www.cjoovs.com/CN/10.3760/cma.j.issn.1674-845X.2014.09.014 或 https://www.cjoovs.com/CN/Y2014/V16/I9/568

[1]	Threatt J， Williamson JF， Huynh K， et al. Ocular disease， knowledge and technology applications in patients with diabetes [J]. Am J Med Scie，2013，345：266-270.
[2]	Schultz RO， Van Horn DL， Peters MA， et al. Diabetic keratopathy[J]. Trans Am Ophthalmol Soc，1981，79：180-199.
[3]	Schultz RO， Matsuda M， Yee RW， et al. Corneal endothelial changes in type I and type II diabetes mellitus[J]. Am J Ophthalmol，1984，98：401-410.
[4]	Friend J， Thoft RA. The diabetic cornea[J]. Int Ophthalmol Clin，1984，24：111-123.
[5]	Kaiserman I， Kaiserman N， Nakar S， et al. Dry eye in diabetic patients[J]. Am J Ophthalmol，2005，139：498-503.
[6]	Xu K， Yu FS. Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats[J]. Invest Ophthalmol Vis Sci，2011，52：3301-3308.
[7]	Xu KP， Li Y， Ljubimov AV， et al. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing[J]. Diabetes，2009，58：1077-1085.
[8]	Dogru M， Katakami C， Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus[J]. Ophthalmology，2001，108：586-592.
[9]	Burnham JM， Sakhalkar M， Langford MP， et al. Diabetic and non-diabetic human cornea and tear gamma-glutamyl transpeptidase activity[J]. Clin Ophthalmol，2013，7：99-107.
[10]	Alves M， Calegari VC， Cunha DA， et al. Increased expression of advanced glycation end-products and their receptor， and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats[J]. Diabetologia，2005，48：2675-2681.
[11]	Dogru M. Tear secretion and tear film function in insulin dependent diabetics[J]. Br J Ophthalmol，2000，84：1210.
[12]	Goebbels M. Tear secretion and tear film function in insulin dependent diabetics[J]. Br J Ophthalmol，2000，84：19-21.
[13]	Kim HJ， Kim PK， Yoo HS， et al. Comparison of tear proteins between healthy and early diabetic retinopathy patients[J]. Clin Biochem，2012，45：60-67.
[14]	Wu YC， Buckner BR， Zhu M， et al. Elevated IGFBP3 levels in diabetic tears： a negative regulator of IGF-1 signaling in the corneal epithelium[J]. Ocul Surf，2012，10：100-107.
[15]	Jacobi C， Jacobi A， Kruse FE， et al. Tear film osmolarity measurements in dry eye disease using electrical impedance technology[J]. Cornea，2011，30：1289-1292.
[16]	Lemp MA， Bron AJ， Baudouin C， et al. Tear osmolarity in the diagnosis and management of dry eye disease[J]. Am J Ophthalmol，2011，151：792-798.
[17]	Sa?/sxdik HM， Ugurbas SH， Can M， et al. Tear film osmolarity in patients with diabetes mellitus[J]. Ophthalmic Res，2013，50：1-5.
[18]	Liu J， Shi B， He S， et al. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy[J]. Mol Vis，2010，16：2931-2938.
[19]	Módulo CM， Jorge AG， Dias AC， et al. Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats[J]. Endocrine，2009，36：161-168.
[20]	Shetty R， Saeed T， Rashed H， et al. Effect of diabetes mellitus on acinar morphology， peroxidase concentration， and release in isolated rat lacrimal glands[J]. Curr Eye Res，2009，34：905-911.
[21]	Inoue K， Kato S， Ohara C， et al. Ocular and systemic factors relevant to diabetic keratoepitheliopathy[J]. Cornea，2001，20： 798-801.
[22]	Inoue K， Okugawa K， Amano S， et al. Blinking and superficial punctate keratopathy in patients with diabetes mellitus[J]. Eye，2005，19：418-421.
[23]	Marfurt CF， Echtenkamp SF. The effect of diabetes on neuropeptide content in the rat cornea and iris[J]. Invest Ophthalmol Vis Sci，1995，36：1100-1106.
[24]	Troger J， Humpel C， Kremser B， et al. The effect of streptozotocin-induced diabetes mellitus on substance P and calcitonin gene-related peptide expression in the rat trigeminal ganglion[J]. Brain Res，1999，842：84-91.
[25]	Watanabe M， Nakayasu K， Iwatsu M， et al. Endogenous substance P in corneal epithelial cells and keratocytes[J]. Nippon Ganka Gakkai Zasshi，2001，105：603-607.
[26]	Wang F， Gao N， Yin J， et al. Reduced innervation and delayed re-innervation after epithelial wounding in type 2 diabetic Goto-Kakizaki rats[J]. Am J Pathol，2012，181：2058-2066.
[27]	He JC， Bazan HEP. Mapping the nerve architecture of diabetic human corneas[J]. Ophthalmology，2012，119：956-964.
[28]	Wang Y， Zhao X， Shi D， et al. Overexpression of SIRT1 promotes high glucose-attenuated corneal epithelial wound healing via p53 regulation of the IGFBP3/IGF-1R/AKT pathway [J]. Invest Ophthalmol Vis Sci，2013，54：3806-3814.
[29]	王晔，赵晓雯，谢立信，等. 沉默信号调控因子1在1型糖尿病模型小鼠角膜和三叉神经节中的表达及意义[J]. 中华实验眼科杂志，2012，30：982-986.
[30]	Najafi L， Malek M， Valojerdi AE， et al. Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus[J]. J Diabetes Complications，2013，27：459-462.
[31]	Rocha EM， Mantelli F， Nominato LF， et al. Hormones and dry eye syndrome： an update on what we do and don′t know [J]. Curr Opin Ophthalmol，2013，24：348-355.
[32]	Manaviat MR， Rashidi M， Afkhami-Ardekani M， et al. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients[J]. BMC Ophthalmol，2008，8：10.
[33]	Tavakoli M， Quattrini C， Abbott C， et al. Corneal confocal microscopy： a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy[J]. Diabetes care，2010，33：1792-1797.
[34]	Saito J， Enoki M， Hara M， et al. Correlation of corneal sensation， but not of basal or reflex tear secretion， with the stage of diabetic retinopathy[J]. Cornea，2003，22：15-18.
[35]	Zhivov A， Winter K， Hovakimyan M， et al. Imaging and quantification of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy[J]. PloS One，2013，8：e52157.
[36]	Ozdemir M， Buyukbese MA， Cetinkaya A， et al. Risk factors for ocular surface disorders in patients with diabetes mellitus [J]. Diabetes Res Clin Pract，2003，59：195-199.
[37]	Nepp J， Abela C， Polzer I， et al. Is there a correlation between the severity of diabetic retinopathy and keratoconjunctivitis sicca?[J]. Cornea，2000，19：487-491.
[38]	Myerburg MM， King JD Jr， Oyster NM， et al. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells[J]. Am J Respir Cell Mol Biol，2010，42：676-684.
[39]	Quaile MP， Melich DH， Jordan HL， et al. Toxicity and toxicokinetics of metformin in rats[J]. Toxicol Appl Pharmacol， 2010，243：340-347.
[40]	Wilson SM， Mansley MK， Getty J， et al. Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney[J]. Br J Pharmacol，2010，159：678-688.
[41]	Jackson JA， Perrigin JA. Relationship of impression cytology and tear ferning to reports of dry eye[J]. J Am Optom Associat， 1999，70：187-192.
[42]	Wang Y， Ogawa Y， Dogru M， et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease[J]. Bone Marrow Transplant，2008，41：293-302.
[43]	Lopin E， Deveney T， Asbell PA. Impression cytology： recent advances and applications in dry eye disease[J]. Ocul Surf，2009，7：93-110.
[44]	Kojima T， Matsumoto Y， Dogru M， et al. The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease[J]. Mol Vis，2010，16：2457-2464.
[45]	Petropoulos IN， Manzoor T， Morgan P， et al. Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology[J]. Cornea，2013，32：83-99.
[46]	李筱荣，王伟，袁佳琴. 共焦显微镜观察2型糖尿病患者角膜神经分布及形态学特征[J]. 中华眼科杂志，2006，42：896-900.
[47]	Rosenberg ME， Tervo TM， Immonen IJ， et al. Corneal structure and sensitivity in type 1 diabetes mellitus[J]. Invest Ophthalmol Vis Sci，2000，41：2915-2921.
[48]	Ziegler D， Papanas N， Zhivov A， et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes[J]. Diabetes，2014， 63：2454-2463.
[49]	Choi SM， Lee YG， Seo MJ， et al. Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation[J]. J Ocul Pharmacol Ther，2009，25：209-214.
[50]	Selvam S， Thomas PB， Gukasyan HJ， et al. Transepithelial bioelectrical properties of rabbit acinar cell monolayers on polyester membrane scaffolds[J]. Am J Physiol Cell Physiol，2007，293：1412-1419.
[51]	Zagon IS， Sassani JW， Immonen JA， et al. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone[J]. Clin Experiment Ophthalmol，2014，42：159-168.
[52]	Cotgreave IA， Schuppe-Koistinen I. A role for gamma-glutamyl transpeptidase in the transport of cystine into human endothelial cells： relationship to intracellular glutathione[J]. Biochim Biophys Acta，1994，1222：375-382.
[53]	Griffith OW， Bridges RJ， Meister A. Transport of gamma-glutamyl amino acids： role of glutathione and gamma-glutamyl transpeptidase[J]. Proc Natl Acad Sci USA，1979，76：6319-6322.
[54]	Abdelkader H， Patel DV， McGhee C， et al. New therapeutic approaches in the treatment of diabetic keratopathy： a review [J]. Clin Experiment Ophthalmol，2011，39：259-270.